<DOC>
	<DOC>NCT00095004</DOC>
	<brief_summary>The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.</brief_summary>
	<brief_title>Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Six month history of migraine; attacks typically mild when they begin with 14 migraine attacks per month. Heart disease High blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>